Gut and the Liver

Preface. <strong>Section I: The `Milieu Extérieur' and `Milieu</strong> <strong>Intérieur' in the Gut: Confrontation and Cooperation.</strong> <strong>1.</strong> Intestinal Microbiota: Control and Overgrowth; A.B. Onderdonk. <strong>2.</strong> The Intestinal Immune System; T. Marth, M. Zeitz. <strong>Section II:</strong> <strong>Gastrointestinal Permeability and Translocation.</strong> <strong>3.</strong> The Intestinal Permeability Barrier - What is Measured, What Does It Mean; S. Gabe, et al. <strong>4.</strong> Bacterial Translocation; R.D. Berg. <strong>5.</strong> Intestinal Permeability in Inflammatory Bowel Disease; <strong>6.</strong> Intestinal Absorption of Small Particles; J. Seifert. <strong>Section III: Bile Acid, Amino Acid and</strong> <strong>Drug Metabolism - It's Not Only the Liver, it May be the Gut.</strong> <strong>7.</strong> State of the Art Lecture: Bacterial Enzymes and Bile Acid Metabolism: Peaceful Coexistence vs. Deadly Warfare; A.F. Hofmann. <strong>8.</strong> Gastric First Pass Metabolism of Alcohol: Interaction with Ammonia and Associated Gastritis; C.S. Lieber. <strong>9.</strong> Ethanol Oxidation and Acetaldehyde Production by Colonic Microbes; M. Salaspuro, et al. <strong>10.</strong> Adaptation of Liver Cell Function to Enteral Resorption: Role of Cell Liver Hydration; D. Hässinger, et al. <strong>11.</strong> Amino Acid Metabolism in the Gut; M. Plauth, A.E. Roske. <strong>12.</strong> Drug Metabolism in the Intestinal Wall; U. Klotz. The Role of Gut Bacteria in Drug Metabolism; T.M. Bauer. <strong>Section IV: Gut-Derived Bacterial Toxins and</strong> <strong>Liver Injury. 14.</strong> How Bacterial Toxins Affect the Intestinal Mucosa - Molecular Mechanism of the Action of Clostridium Difficile Toxins; K. Aktories. <strong>15.</strong> Acute and Chronic Endotoxemia: Effects on Hepatic Neutrophil Influx and Respiratory Burst; J.A. Spitzer. <strong>16.</strong> Experimental Liver Injury: The Role of Lipopolysaccharides and Cytokines; A. Wendel, et al. <strong>17.</strong> Endotoxin, Kupffer Cells and Alcoholic Liver Injury; R.G. Thurman, et al. <strong>18.</strong> Hepatic Injury and Biliary Tract Diseases Associated with Small Intestinal Bacterial Overgrowth; R.B. Sartor, S.N. Lichtman. <strong>19.</strong> Endotoxemia in Chronic Hepatitis and Cirrhosis: Epiphenomenon or of Pathological Relevance? H. Fukui, et al. <strong>20.</strong> Endotoxemia and Disseminated Intravascular Coagulation in Cirrhosis; F. Violi, et al. <strong>21.</strong> The Role of Gut-Derived Bacterial Toxins (Endotoxin) for the Development of Alcoholic Liver Disease in Man; Ch. Bode, et al. <strong>22.</strong> Endotoxaemia and Cholestasis; E. Walter. <strong>23.</strong> Adverse Effects of Gut-Derived Bacterial Toxins in Liver Transplantation; W. Lauchart. <strong>Section V: Gastrointestinal Dysfunction</strong> <strong>in Liver Disease.</strong> <strong>24.</strong> Altered Gastrointestinal Motility in Chronic Liver Disease; R.K. Zetterman. <strong>25.</strong> Portal Hypertensive Intestinal Vasculopathy; T.R. Viggiano. <strong>26.</strong> Role of Lipopolysaccharide and Inducible Nitric Oxide Synthase in Gastrointestinal and Hepatic Disease: Actions of Selective Inhibition of iNOS on Microvascular Integrity in the Gut and Liver; F. L&aacute;szl&oacute;, et al. <strong>27.</strong> Bacterial Overgrowth in the Small Intestine in Chronic Liver Disease; F. Casafont, et al. <strong>Section VI: Spontaneous Bacterial Peritonitis in</strong> <strong>Cirrhotics.</strong> <strong>28.</strong> Spontaneous Bacterial Peritonitis Incidence, Diagnosis and Clinical Course; A. Ochs. <strong>29.</strong> Treatment and Prophylaxis of Spontaneous Bacterial Peritonitis; A. Rimola, et al. <strong>Section VII:</strong> <strong>Liver Injury in Patients with Diseases of the Gastrointestinal Tract.</strong> <strong>30.</strong> Haemochromatosis: A Defect in Gut Transport Leads to Liver Injury; W. Stremmel, et al. <strong>31.</strong> Liver and Biliary Abnormalities in Ulcerative Colitis and Crohn's Disease; R.H. Wiesner. <strong>32.</strong> Liver Abnormalities in Coeliac Disease; M.B. Jacobsen. <strong>33.</strong> Primary Sclerosing Cholangitis: New Therapeutic Strategies; A. Stiehl, et al. <strong>34.</strong> Jejunoileal Bypass: An Unintended Model of Steatophepatitis (Nash Syndrome) in Man; D.L. Kaminski. Index.